Visual field defects and reduced visual acuity during pregnancy in two patients with prolactinoma: Rapid regression of symptoms under bromocriptine. Case reports

P. Crosignani, C. Ferrari, A. M. Mattei

Research output: Contribution to journalArticlepeer-review

Abstract

Safety of bromocriptine during pregnancy has been recently documented in a large series of pregnancies by Turkalj et al. (1982), who found no excess rate of abortion, twins, or malformations in 1410 children observed. In our two patients treatment was empirically continued until term, and for at least 2 months after delivery. Whether this cautious attitude which includes inhibition of puerperal lactation is justified remains to be established.

Original languageEnglish
Pages (from-to)821-823
Number of pages3
JournalBritish Journal of Obstetrics and Gynaecology
Volume91
Issue number8
Publication statusPublished - 1984

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Fingerprint Dive into the research topics of 'Visual field defects and reduced visual acuity during pregnancy in two patients with prolactinoma: Rapid regression of symptoms under bromocriptine. Case reports'. Together they form a unique fingerprint.

Cite this